Approval · Notice of Compliance 30132 · 2023
FLUOXETINE: Notice of Compliance 30132
Issued February 15, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30132
- Date
- February 15, 2023
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUOXETINE | 02374447 | Marketed |
| FLUOXETINE | 02374455 | Marketed |
Medicinal ingredients
- FLUOXETINE 10 MG per CAP
- FLUOXETINE 20 MG per CAP